The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients.
Saved in:
| Title: | The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients. |
|---|---|
| Authors: | Ismail G; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France., Zeineddine M; School of Pharmacy, Lebanese American University, Byblos, Lebanon. Electronic address: mzeineddine39@gmail.com., Al-Roughani R; Amiri Hospital, Kuwait, Kuwait., Ahmed SF; Ibn Sina Hospital, Kuwait, Kuwait., Al-Mahdawi A; Baghdad Medical City Teaching Hospital, Baghdad, Iraq., Khoury S; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon., El-Ayoubi N; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon., Inshasi J; MS Department, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates., Al-Khabouri J; Department of Neurology, The Royal Hospital, Muscat, Oman., Al-Asmi A; Neurology Unit, Department of Medicine, College of Medicine and Health Sciences and Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman., Gouider R; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health'- Razi University Hospital- Mannouba, Tunis, Tunisia., Aljarallah S; King Saud University, King Saud University Medical City, Riyadh, Saudi Arabia., Alkhawajah N; King Saud University, King Saud University Medical City, Riyadh, Saudi Arabia., Al Malik Y; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Department of Neurology, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia., Abulaban A; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Department of Neurology, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia., Makkawi S; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; Department of Neurology, Ministry of the National Guard-Health Affairs, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Khojah O; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; Department of Neurology, Ministry of the National Guard-Health Affairs, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., El-Hajj T; Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon., Massouh J; Neurology Institute, Harley Street Medical Centre, Abu Dhabi, United Arab Emirates., AlSalamat H; Faculty of Medicine, Al-Balqa Applied University, Al-Salt 19117, Jordan., Al-Hajje A; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon., Salameh P; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon; School of Medicine, Lebanese American University, Byblos, Lebanon; Department of Primary Care and Population Health, University of Nicosia Medical School, 2417, Nicosia, Cyprus., Boumediene F; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France., Yamout B; Neurology Institute, Harley Street Medical Centre, Abu Dhabi, United Arab Emirates. |
| Source: | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2026 Mar; Vol. 23 (2), pp. e00861. Date of Electronic Publication: 2026 Mar 12. |
| Publication Type: | Journal Article; Observational Study; Multicenter Study |
| Journal Info: | Publisher: Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics Country of Publication: United States NLM ID: 101290381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7479 (Electronic) Linking ISSN: 18787479 NLM ISO Abbreviation: Neurotherapeutics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
